Lipidomics Equipment Market is expected to reach US$ 2,662.67 Million by 2028

The lipidomics equipment market size is expected to reach US$ 2,662.67 million by 2028  and it is registering at a CAGR of 14.7% from 2022 to 2028, according to a new research study conducted by The Insight Partners.

Based on Type Segment, The Targeted Segment To Account for Largest Share in Global Lipidomics Equipment Market During 2022–2028

Technological Advancement in Lipidomics Equipment Boosts Overall Market Growth

Mass spectrometers are commonly used for the identification and quantification of lipids. Several advanced mass spectrometers, including sector mass spectrometry, matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF), liquid chromatography-mass spectrometry (LC-MS), and tandem mass spectrometer, have been made available for researchers and technicians. Further, these instruments are integrated with automation, miniaturization, artificial intelligence (AI), and smart technologies to enhance their efficiency and accuracy. In 2018, Thermo Scientific launched Genesys 50 UV/vis spectrometer with a single cell configuration for low sample throughput needs, with a removable, washable sampling compartment for easy clean-up. In the same year, Shimadzu, in collaboration with PREMIER Biosoft, launched Shimadzu's LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system for lipidomics and glycomics data analysis; the product features informatics support powered by software solutions of PREMIER Biosoft. Therefore, the technological advancements in mass spectrometry are driving the market's growth during the forecast period.

Global Lipidomics Equipment Market, by Region, 2021 (%)

Based on type, the global Lipidomics Equipment market is bifurcated into targeted and untargeted. The targeted segment accounted for the largest market share in 2021 and is expected to register the highest CAGR from 2022 to 2028. Based on offerings, the market is MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment is further subsegmented into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others. In 2021, the MS-based lipidomics techniques segment held the largest market share; however, the software & services segment is expected to grow at the fastest CAGR of 15.4% during the coming years. Based on services, the global lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. Based on end user, the global Lipidomics Equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. In 2021, the molecular research segment held the largest market share; however, the clinical research segment is expected to grow at the fastest CAGR of 15.2% during the coming years.

The outbreak of COVID-19 had a slightly negative impact on the growth of the lipidomics equipment market as production facilities for major manufacturers were closed. Most key players tried to supply their products to the customers through various channels but are facing problems due to the limited manufacturing and disturbance caused by the pandemic. For instance, the annual sales of Bruker Corporation have been affected significantly due to coronavirus pandemic. The company's first-quarter 2020 results reflected a decline in both reported and organic revenue, mainly due to COVID-19 disruptions. Various conferences related to lipidomics equipment are being conducted through webinars. Hence, it is expected to boost the market's growth during the forecast period.

Thermofisher Scientific; Creative Proteomics; IonBench; Shimadzu Europe GMbH; Bruker; Agilent Technologies Inc; PerkinElmer, Inc.; Sciex; Metabolon, Inc.; and Cayman Chemical are among the leading companies operating in the global Lipidomics Equipment market.    

Various organic and inorganic strategies are adopted by companies operating in the global Lipidomics Equipment market. Organic strategies mainly include product launches and product approvals. Further, acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the significant developments by key players operating in the global Lipidomics Equipment market are listed below.

• In April 2022, Bruker acquired IonSense, a leader in ambient ionization and developer of the DART mass spectrometer that can analyze many types of samples, including solids, liquids, and gases, in seconds with little to no sample preparation before analysis.
• In March 2022, Bruker Corporation collaborated with Newomics Inc, a biotechnology company commercializing mass spectrometry solutions for molecular detection, on a novel LC-MS platform for drug discovery in the pharma/biopharma industry as a research institution.
• In September 2021, Thermofisher Scientific launched Vanish Neo UHPLC System, which will transform how scientists perform proteomics studies, coupled with PepMap Columns and high-resolution accurate mass (HRAM) systems.
• In May 2021, Thermofisher Scientific launched Orbitrap Exploris GC-MS, bringing high-resolution analysis into everyday testing in a compact and easy-to-use instrument, delivering leading sensitivity and mass resolving power up to 60,000.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com